Duaklir Pressair

Active Ingredient(s): Aclidinium Bromide + Formoterol Fumarate
FDA Approved: * March 29, 2019
Category: Lungs (Pulmonary)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Duaklir Pressair Overview

Aclidinium bromide/formoterol, sold under the brand names Duaklir and Brimica, is a fixed-dose combination medication for inhalation, used in the management of chronic obstructive pulmonary disease (COPD). It consists of aclidinium bromide, a long-acting muscarinic antagonist, and formoterol, a long-acting β2 agonist.[2][3] References ^ "Duaklir Genuair 340 micrograms /12 micrograms inhalation powder - Summary of Product Characteristics (SmPC)". (emc)...

Read more Duaklir Pressair Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Aclidinium/formoterol

Recent Duaklir Pressair Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Aclidinium Bromide + Formoterol Fumarate
  • Powder, Metered: 0.4mg/inh + 0.012mg/inh
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Duaklir Pressair: (1 result)

Sorted by National Drug Code
  • 72124-001 Duaklir Pressair Respiratory (Inhalation) Powder, Metered by Circassia Pharmaceuticals Inc.

Drugs with one or more similar ingredients: (12 results)

Related Duaklir Pressair Topics:

Tudorza Pressair Coupon
I am looking for a coupon or discount to offset the amount that my health insurance does not cover ## As far as saving m... 1 reply
Tudorza pressair coverd by insurance
Is tudorza pressair covered by bcbsil, what is co pay?...

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 23 October 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA